Skip to content

Effect Of Abhaya Arishtadi Ghana Vati in Psoriasis.

Randomized Clinical Trial On Effect Of Abhaya Arishtadi Ghana Vati In The Management Of Psoriasis. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076740
Enrollment
100
Registered
2024-11-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

None listed

Sponsors

G J Patel Institute of Ayurveda Studies and Research Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient who fulfills the diagnostic criteria of psoriasis. 2. Patient who has chronicity of less than 5 years will be taken. 3. PASI score – 0-10 will be taken.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women. 2. Patients with any other skin diseases. 3. Patients with associated diseases like cardiovascular disorders, hyperthyroidism or hypothyroidism, cancer, tuberculosis, heart diseases, psoriatic arthritis, and kidney and liver disorders. 4. Patients who have taken medication of corticosteroids or drugs within the last 3 months

Design outcomes

Primary

MeasureTime frame
Improvement in the subjective and objective criteria of psoriasis with intervention of Abhaya Arishtadi Ghana Vati. Timepoint: 7th,14th,21st,30th days

Secondary

MeasureTime frame
To explore the etio-pathological role of dietary factor in psoriasis. Timepoint: 1month

Countries

India

Contacts

Public ContactDr Dhara Deliwala

G J Patel Institute of Ayurveda Studies and Research Center

yogesh.deole@cvmu.edu.in9974999309

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026